Société Rocket Pharmaceuticals, Inc.
Actions
RCKT
US77313F1066
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
21,98 USD | -0,54 % | -3,60 % | -26,66 % |
Métier
Nombre d'employés: 268
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04/01/18 |
Kinnari Patel
PSD | President | 46 | 04/01/18 |
Chief Tech/Sci/R&D Officer | 60 | 01/01/16 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 27/07/22 |
David Southwell
BRD | Director/Board Member | 63 | 01/08/14 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 04/04/23 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 07/09/21 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 01/05/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 04/01/18 |
Carsten Boess
BRD | Director/Board Member | 57 | 01/01/16 |
David Southwell
BRD | Director/Board Member | 63 | 01/08/14 |
Rod Wong
CHM | Chairman | 47 | 01/01/18 |
Director/Board Member | 47 | 01/01/18 | |
Gotham Makker
BRD | Director/Board Member | 50 | 04/01/18 |
Fady Malik
BRD | Director/Board Member | 59 | 10/03/22 |
Director/Board Member | 63 | 20/04/20 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04/01/18 |
R. Woods
BRD | Director/Board Member | 57 | 12/12 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 90 504 248 | 85 462 800 ( 94,43 %) | 0 | 94,43 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-26,66 % | 1,99 Md | |
-2,31 % | 103 Md | |
+0,56 % | 95,28 Md | |
+1,69 % | 22,15 Md | |
-17,37 % | 21,02 Md | |
-9,30 % | 18,15 Md | |
-41,01 % | 16,73 Md | |
-14,85 % | 16,05 Md | |
+3,21 % | 13,68 Md | |
+33,54 % | 12,17 Md |
- Bourse
- Actions
- Action RCKT
- Société Rocket Pharmaceuticals, Inc.